180 Life Sciences announced the appointment of Omar Jimenez as its new CFO, effective September 30. Jimenez, already a director of the company, will play a role in driving the financial strategy of the company.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATNF:
- 180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer
- 180 Life Sciences announces results from study testing new solid formula of CBD
- 180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake
- 180 Life Sciences granted additional extension by Nasdaq to regain compliance
- 180 Life Sciences files to sell common stock, warrants, no amount given